New drug AZD1613 tested for safety in kidney disease patients

NCT ID NCT07228364

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This early-stage study tests the safety of a new drug called AZD1613 in 40 adults with autosomal dominant polycystic kidney disease (ADPKD), a condition that causes kidney cysts. Participants receive either the drug or a placebo to check for side effects and how the drug moves through the body. The goal is to see if the drug is safe enough for further testing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autosomal dominant polycystic kidney disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

Contacts and locations

Locations

Research Site
NOT_YET_RECRUITING

Birmingham, Alabama, 35233, United States
Research Site
NOT_YET_RECRUITING

Loma Linda, California, 92354, United States
Research Site
RECRUITING

Jacksonville, Florida, 32216, United States
Research Site
RECRUITING

Orlando, Florida, 32808, United States
Research Site
RECRUITING

Lenexa, Kansas, 66219, United States
Research Site
NOT_YET_RECRUITING

Baltimore, Maryland, 21201, United States
Research Site
RECRUITING

Rochester, Minnesota, 55905, United States
Research Site
NOT_YET_RECRUITING

San Antonio, Texas, 78212, United States
Research Site
NOT_YET_RECRUITING

Chengdu, 610072, China
Research Site
NOT_YET_RECRUITING

Hangzhou, 310003, China
Research Site
RECRUITING

Nanjing, 210009, China
Research Site
NOT_YET_RECRUITING

Shanghai, 200025, China
Research Site
NOT_YET_RECRUITING

Wuhan, 430022, China
Research Site
NOT_YET_RECRUITING

Xiamen, 361101, China
Research Site
RECRUITING

London, NW3 2QG, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.